Jump to content

USP7

From Wikipedia, the free encyclopedia
(Redirected from USP7 (gene))

USP7
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesUSP7, HAUSP, TEF1, ubiquitin specific peptidase 7 (herpes virus-associated), ubiquitin specific peptidase 7, HAFOUS
External IDsOMIM: 602519; MGI: 2182061; HomoloGene: 2592; GeneCards: USP7; OMA:USP7 - orthologs
Orthologs
SpeciesHumanMouse
Entrez

7874

252870

Ensembl

ENSG00000187555

ENSMUSG00000022710

UniProt

Q93009

Q6A4J8

RefSeq (mRNA)

NM_003470
NM_001286457
NM_001286458
NM_001321858

NM_001003918

RefSeq (protein)

NP_001273386
NP_001273387
NP_001308787
NP_003461

NP_001003918

Location (UCSC)Chr 16: 8.89 – 8.98 MbChr 16: 8.51 – 8.61 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Ubiquitin-specific-processing protease 7 (USP7), also known as ubiquitin carboxyl-terminal hydrolase 7 or herpesvirus-associated ubiquitin-specific protease (HAUSP), is an enzyme that in humans is encoded by the USP7 gene.[5][6][7][8]

Function

[edit]

Regulation of the p53 tumor suppressor

[edit]

USP7 or HAUSP is a ubiquitin specific protease or a deubiquitylating enzyme that cleaves ubiquitin from its substrates.[9] Since ubiquitylation (polyubiquitination) is most commonly associated with the stability and degradation of cellular proteins, HAUSP activity generally stabilizes its substrate proteins.

HAUSP is most popularly known as a direct antagonist of Mdm2, the E3 ubiquitin ligase for the tumor suppressor protein, p53.[10] Normally, p53 levels are kept low in part due to Mdm2-mediated ubiquitylation and degradation of p53. In response to oncogenic insults, HAUSP can deubiquitinate p53 and protect p53 from Mdm2-mediated degradation, indicating that it may possess a tumor suppressor function for the immediate stabilization of p53 in response to stress.

Another important role of HAUSP function involves the oncogenic stabilization of p53. Oncogenes such as Myc and E1A are thought to activate p53 through a p19 alternative reading frame (p19ARF, also called ARF)-dependent pathway, although some evidence suggests ARF is not essential in this process. A possibility is that HAUSP provides an alternative pathway for safeguarding the cell against oncogenic insults.

Role in transcriptional regulation

[edit]

USP7 can deubiquitinate histone H2B and this activity is associated with gene silencing in Drosophila.[11] USP7 associates with a metabolic enzyme, GMP synthetase (GMPS) and this association stimulates USP7 deubiquitinase activity towards H2B.[11] The USP7-GMPS complex is recruited to the polycomb (Pc) region in Drosophila and contributes to epigenetic silencing of homeotic genes.[12] USP7 also controls histone H2A monoubiquitylation (H2AK119ub1), known to repress gene expression, by noncanonical Polycomb-repressive complexes (ncPRC1s).[13]

Role in drug addiction

[edit]

USP7, in conjunction with the scaffold protein Maged1, mediates the monoubiquitination of histone H2A in the paraventricular thalamus, a non-canonical reward region of the brain.[14][15] This modification is significantly increased in response to chronic cocaine use, contributing to cocaine-adaptive behaviors and transcriptional repression in mice.[14] Furthermore, genetic variations in MAGED1 and USP7 are associated with altered susceptibility to cocaine addiction and cocaine-induced behaviors in humans.[14] These findings reveal an important epigenetic mechanism involving USP7 that regulates the risk and behavioral response to cocaine addiction, positioning USP7 as a potential therapeutic target for cocaine use disorder.[14]

Association with herpesviruses

[edit]

USP7 was originally identified as a protein associated with the ICP0 protein of herpes simplex virus (HSV), hence the name Herpesvirus Associated USP (HAUSP). ICP0 is an E3-ubiquitin ligase that is involved in ubiquitination and subsequent degradation of itself and certain cellular proteins. USP7 has been shown to regulate the auto-ubiquitination and degradation of ICP0.

More recently, an interaction between USP7 and the EBNA1 protein of Epstein–Barr virus (EBV) (another herpesvirus) was also discovered.[16] This interaction is particularly interesting given the oncogenic potential (potential to cause cancer) of EBV, which is associated with several human cancers. EBNA1 can compete with p53 for binding USP7. Stabilization by USP7 is important for the tumor suppressor function of p53. In cells, EBNA1 can sequester USP7 from p53 and thus attenuate stabilization of p53, rendering the cells predisposed to turning cancerous. Compromising the function of p53 by sequestering USP7 is one way EBNA1 can contribute to the oncogenic potential of EBV. Additionally, human USP7 was also shown to form a complex with GMPS and this complex is recruited to EBV genome sequences.[17] USP7 was shown to be important for histone H2B deubiquitination in human cells and for deubiquitination of histone H2B incorporated in the EBV genome. Thus USP7 may also be important for regulation of viral gene expression.

The fact that viral proteins have evolved so as to target USP7, underscores the significance of USP7 in tumor suppression and other cellular processes.

Binding partners

[edit]

The following is a list of some of the known cellular binding partners of USP7/HAUSP:

Interactions

[edit]

USP7 has been shown to interact with Ataxin 1,[20] CLSPN,[21] P53,[10] and more recently with MAGED1 and histone H2A through its function in the polycomb repressive complex.[14] A proteomic screen conducted to identify interacting partners of 75 human deubiquitinating enzymes (DUBs) has revealed several novel binding partners of USP7.[22]

Clinical significance

[edit]

Loss-of-function mutations of USP7 are associated with neurodevelopmental disorder whose symptoms include developmental delay/intellectual disability, autism spectrum disorder, increased prevalence of epilepsy, abnormal brain MRIs, and speech/motor impairments, with some patients being completely non-verbal,[23][24]

USP7 can be used as a senolytic agent due to ubiquitination and subsequent proteasome degradation of mdm2, thereby increasing p53 activity.[18]

References

[edit]
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000187555 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000022710 – Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Puente XS, Sánchez LM, Overall CM, López-Otín C (Jul 2003). "Human and mouse proteases: a comparative genomic approach". Nature Reviews. Genetics. 4 (7): 544–58. doi:10.1038/nrg1111. PMID 12838346. S2CID 2856065.
  6. ^ Robinson PA, Lomonte P, Markham AF, Everett RD (Mar 1999). "Assignment1 of herpesvirus-associated ubiquitin-specific protease gene HAUSP to human chromosome band 16p13.3 by in situ hybridization". Cytogenetics and Cell Genetics. 83 (1–2): 100. doi:10.1159/000015142. PMID 9925944. S2CID 34084848.
  7. ^ "Entrez Gene: USP7 ubiquitin specific peptidase 7 (herpes virus-associated)".
  8. ^ Everett RD, Meredith M, Orr A, Cross A, Kathoria M, Parkinson J (Apr 1997). "A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein". The EMBO Journal. 16 (7): 1519–30. doi:10.1093/emboj/16.7.1519. PMC 1169756. PMID 9130697.
  9. ^ Holowaty MN, Sheng Y, Nguyen T, Arrowsmith C, Frappier L (Nov 2003). "Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP". The Journal of Biological Chemistry. 278 (48): 47753–61. doi:10.1074/jbc.M307200200. PMID 14506283.
  10. ^ a b Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J, et al. (Apr 2002). "Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization". Nature. 416 (6881): 648–53. Bibcode:2002Natur.416..648L. doi:10.1038/nature737. PMID 11923872. S2CID 4389394.
  11. ^ a b van der Knaap JA, Kumar BR, Moshkin YM, Langenberg K, Krijgsveld J, Heck AJ, et al. (Mar 2005). "GMP synthetase stimulates histone H2B deubiquitylation by the epigenetic silencer USP7". Molecular Cell. 17 (5): 695–707. doi:10.1016/j.molcel.2005.02.013. PMID 15749019.
  12. ^ van der Knaap JA, Kozhevnikova E, Langenberg K, Moshkin YM, Verrijzer CP (Feb 2010). "Biosynthetic enzyme GMP synthetase cooperates with ubiquitin-specific protease 7 in transcriptional regulation of ecdysteroid target genes". Molecular and Cellular Biology. 30 (3): 736–44. doi:10.1128/MCB.01121-09. PMC 2812229. PMID 19995917.
  13. ^ Sijm A, Atlasi Y, van der Knaap JA, Wolf van der Meer J, Chalkley GE, Bezstarosti K, et al. (2022). "USP7 regulates the ncPRC1 Polycomb axis to stimulate genomic H2AK119ub1 deposition uncoupled from H3K27me3". Science Advances. 8 (44): eabq7598. doi:10.1126/sciadv.abq7598. PMC 9635827. PMID 36332031.
  14. ^ a b c d e Cheron J, Beccari L, Hagué P, Icick R, Despontin C, Carusone T, et al. (December 2023). "USP7/Maged1-mediated H2A monoubiquitination in the paraventricular thalamus: an epigenetic mechanism involved in cocaine use disorder". Nature Communications. 14 (1): 8481. Bibcode:2023NatCo..14.8481C. doi:10.1038/s41467-023-44120-2. PMC 10733359. PMID 38123574.{{cite journal}}: CS1 maint: overridden setting (link)
  15. ^ Zhou K, Zhu Y (April 2019). "The paraventricular thalamic nucleus: A key hub of neural circuits underlying drug addiction". Pharmacological Research. 142: 70–76. doi:10.1016/j.phrs.2019.02.014. PMID 30772461.
  16. ^ Holowaty MN, Frappier L (Nov 2004). "HAUSP/USP7 as an Epstein-Barr virus target". Biochemical Society Transactions. 32 (Pt 5): 731–2. doi:10.1042/BST0320731. PMID 15494000.
  17. ^ Sarkari F, Sanchez-Alcaraz T, Wang S, Holowaty MN, Sheng Y, Frappier L (Oct 2009). Speck SH (ed.). "EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication". PLOS Pathogens. 5 (10): e1000624. doi:10.1371/journal.ppat.1000624. PMC 2757719. PMID 19834552.
  18. ^ a b He Y, Li W, Lv D, Zhang X, Zhang X, Ortiz YT, et al. (2020). "Inhibition of USP7 activity selectively eliminates senescent cells in part via restoration of p53 activity". Aging Cell. 19 (3): e13117. doi:10.1111/acel.13117. PMC 7059172. PMID 32064756.
  19. ^ Schwertman P, Lagarou A, Dekkers DH, Raams A, van der Hoek AC, Laffeber C, et al. (May 2012). "UV-sensitive syndrome protein UVSSA recruits USP7 to regulate transcription-coupled repair". Nature Genetics. 44 (5): 598–602. doi:10.1038/ng.2230. PMID 22466611. S2CID 5486230.
  20. ^ Hong S, Kim SJ, Ka S, Choi I, Kang S (June 2002). "USP7, a ubiquitin-specific protease, interacts with ataxin-1, the SCA1 gene product". Molecular and Cellular Neurosciences. 20 (2): 298–306. doi:10.1006/mcne.2002.1103. PMID 12093161. S2CID 41295664.
  21. ^ Faustrup H, Bekker-Jensen S, Bartek J, Lukas J, Mailand N (January 2009). "USP7 counteracts SCFbetaTrCP- but not APCCdh1-mediated proteolysis of Claspin". The Journal of Cell Biology. 184 (1): 13–19. doi:10.1083/jcb.200807137. PMC 2615094. PMID 19124652.
  22. ^ Sowa ME, Bennett EJ, Gygi SP, Harper JW (July 2009). "Defining the human deubiquitinating enzyme interaction landscape". Cell. 138 (2): 389–403. doi:10.1016/j.cell.2009.04.042. PMC 2716422. PMID 19615732.
  23. ^ Hao YH, Fountain MD, Fon Tacer K, Xia F, Bi W, Kang SH, et al. (September 2015). "USP7 Acts as a Molecular Rheostat to Promote WASH-Dependent Endosomal Protein Recycling and Is Mutated in a Human Neurodevelopmental Disorder". Mol. Cell. 59 (6): 956–69. doi:10.1016/j.molcel.2015.07.033. PMC 4575888. PMID 26365382.
  24. ^ "USP7 Related Diseases". National Organization for Rare Disorders (NORD).

Further reading

[edit]
[edit]
  • Overview of all the structural information available in the PDB for UniProt: Q93009 (Ubiquitin carboxyl-terminal hydrolase 7) at the PDBe-KB.
Retrieved from "https://en.wikipedia.org/w/index.php?title=USP7&oldid=1246728459"